Brief: Moberg Pharma And Taisho Sign Exclusive License Agreement For Mob-015 In Japan

Moberg Pharma AB (publ)

30/09/2019 17:09

Sept 30 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA AND TAISHO SIGN EXCLUSIVE LICENSE AGREEMENT
FOR
MOB-015 IN JAPAN
    * MOBERG PHARMA- ELIGIBLE TO RECEIVE MILESTONES OF UP TO $50
MILLION CONTINGENT ON DEVELOPMENT & COMMERCIAL SUCCESS, AS WELL
AS SUPPLY FEES INCLUDING ROYALTIES.
    * MOBERG PHARMA AB - MAJORITY OF MILESTONE PAYMENTS ARE
CONTINGENT
ON SALES TARGETS, WITH BALANCE CONTINGENT ON DEVELOPMENT AND
REGULATORY MILESTONES.

Source text for Eikon:  ID:nWkr6psJ57 
Further company coverage:  MBPH.ST 

 ((Reuters.Briefs@thomsonreuters.com;))